Your Article Summary
See Latest ArticlesElevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
Arthritis Research & Therapy, 09/05/08
Rosengren S et al. – Combined with earlier observations that synovial lymphoid aggregates survived rituximab treatment, these data suggest that lymphoid aggregates may provide a protective niche for autoantibody producing cells.
Methods- Study to evaluate the contribution of synovial lymphoid aggregates to autoantibody, total immunoglobulin production in RA pts, and the effect of the B-cell depleting ab, rituximab
- Autoantibodies, total IgM and IgG were quantified by ELISA in extracts of synovial tissues and matched serum
- Synovial biopsies and serum were obtained at baseline and 8 wks following rituximab therapy in 14 RA pts
- Anti-CCP IgG, but not RF-IgM, was enriched in RA synovia vs serum
- Total IgM and IgG was also enriched in RA, but not in OA
- SSI correlated with mRNA content for both IgM and IgG
- RA synovia with lymphocyte aggregates contained elevated RF-IgM and anti-CCP IgG vs tissues with diffuse lymphoid infiltration
- Rituximab treatment did not affect synovial autoantibody or total Ig SSI overall
- In aggregate-containing tissues, rituximab reduced total IgM and IgG SSI as well as IgM and IgG1 mRNA
- RF-IgM and anti-CCP IgG synovial/serum indices were unchanged by rituximab in aggregate-containing synovial
Related Articles
Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial
Clinical Therapeutics, 10/15/09
Relevance Score: 71%
Certolizumab Pegol: In Rheumatoid Arthritis
BioDrugs, 11/11/09
Relevance Score: 70%
Assistive technology for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 69%
Abatacept for rheumatoid arthritis
Cochrane Reviews, 10/09/09
Relevance Score: 69%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Rheumatology, 12/20/09
The 'RASor's' edge: Ras proteins and matrix destruction in arthritis
Arthritis Research & Therapy, 12/19/09
Unresponsiveness to colchicine therapy in patients with familial Mediterranean fever homozygous for the M694V mutation
Journal of Rheumatology, 12/17/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignancy-associated multicentric reticulohistiocytosis
Rheumatology International, 12/20/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: A case series
Rheumatology, 12/18/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the genetic risk factors for rheumatoid arthritis
Expert Review of Clinical Immunology, 12/20/09
Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study
Arthritis Research & Therapy, 12/20/09
The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
Rheumatology International, 12/18/09